Shisong Han
Zhuhai, 519099, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Target Identification of the Hepatocellular Carcinoma-Specific Aptamer JHIT2e and Construction of Engineered Nanotrains for Synergistic Chemoradiotherapy.
Journal: Molecular pharmaceutics
Published: January 23, 2026
GLP-1 regulates osteo-adipogenic fate of BMSCs via HIF-2-AKT signaling and supports trabecular bone in glucocorticoid-induced osteoporosis.
Journal: Stem cell reports
Published: September 19, 2025
Corrigendum to "A nanodrug loading indocyanine green and metformin dually alleviating tumor hypoxia for enhanced chemodynamic/sonodynamic therapy" [J. Colloid Interface Sci. 680(Part B) (2025) 341-355].
Journal: Journal of colloid and interface science
Published: December 14, 2024
Resistance of first-line targeted drugs in hepatocellular carcinoma: the epigenetic regulation mechanisms.
Journal: Cell death & disease
Published: October 20, 2024
A nanodrug loading indocyanine green and metformin dually alleviating tumor hypoxia for enhanced chemodynamic/sonodynamic therapy.
Journal: Journal of colloid and interface science
Published: September 30, 2024
Biodegradable silk fibroin membranes for potential localized treatment of melanoma: optimized preparation andin vitrostudy.
Journal: Biomedical materials (Bristol, England)
Published: July 30, 2024
HIF-2α-driven Lipogenesis and Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease: Role of ATF4 Signaling.
Journal: Cellular and molecular gastroenterology and hepatology
Published: May 09, 2024
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 07, 2024
A chemodynamic nanoenzyme with highly efficient Fenton reaction for cancer therapy.
Journal: Biomedical materials (Bristol, England)
Published: May 19, 2023
Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy.
Journal: International journal of biological macromolecules
Published: March 01, 2023
Last Updated: 09/26/2026